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Women diagnosed with breast cancer in the UK display marked differences in survival between categories defined by socio-
economic deprivation. Timeliness of diagnosis is one of the possible explanations for these patterns. Women whose cancer is
screen-detected are more likely to be diagnosed at an earlier stage. We examined deprivation and screening-specific survival in
order to evaluate the role of early diagnosis upon deprivation-specific survival differences in the West Midlands (UK) and New
South Wales (Australia). We estimated net survival for women aged 50–65 years at diagnosis and whom had been continuously
eligible for screening from the age of 50. Records for 5,628 women in West Midlands (98.5% of those eligible, mean age at diag-
nosis 53.7 years) and 6,396 women in New South Wales (99.9% of those eligible, mean age at diagnosis 53.8 years). In New
South Wales, survival was similar amongst affluent and deprived women, regardless of whether their cancer was screen-detected
or not. In the West Midlands, there were large and persistent differences in survival between affluent and deprived women. Depri-
vation differences were similar between the screen-detected and non-screen detected groups. These differences are unlikely to
be solely explained by artefact, or by patient or tumour factors. Further investigations into the timeliness and appropriateness of
the treatments received by women with breast cancer across the social spectrum in the UK are warranted.
Despite advances in survival amongst women diagnosed with
invasive breast cancer in recent decades, women in the UK dis-
play marked differences in survival between categories deﬁned
by socioeconomic deprivation.1–4 The survival differentials
have narrowed more recently, but more deprived women are
still at a considerable disadvantage over afﬂuent women.3,5
These inequalities are a key focus of public health policy.6
Later diagnosis amongst the more deprived groups, associ-
ated with later stage of disease at presentation, is one of the
possible explanations for these patterns.7 Women whose
breast cancer is screen-detected are usually asymptomatic
and are often diagnosed at an earlier stage than women diag-
nosed following symptomatic presentation. It has previously
been shown that deprivation differences in screen-detected
survival are smaller than for those who present symptomati-
cally.8 Screening thus provides an opportunity to examine the
contributions of the timeliness of diagnosis and stage of dis-
ease to socioeconomic differences in survival. In a companion
article, we have examined international differences in survival
between screened and non-screened women from West Mid-
lands and New South Wales who had been eligible for
screening from their 50th birthday.9 We found that net sur-
vival was persistently higher in New South Wales than in the
West Midlands, among both screen-detected and non-screen-
detected women. Here, we examine socioeconomic differen-
ces in net survival among the same women, and we compare
the patterns observed in Australia and England.
Materials
The data have been described.9 Brieﬂy, the cohort consisted
of women diagnosed with an invasive, primary breast cancer
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at age 50–65 years during the period January 1, 1997 to
December 31, 2006 and aged 51 years or younger on 1 Janu-
ary 1997. These very speciﬁc eligibility criteria were designed
to include only women who had been consistently eligible for
population-based mammographic screening throughout the
period 1997 to 2006. The resulting cohort gradually increased
over time: the median month of diagnosis was August 2003
in West Midlands and November 2003 in New South Wales.
All women were followed up to December 31, 2008. Informa-
tion was obtained on each woman’s age at diagnosis (com-
pleted years); the month and year of diagnosis and (if dead)
of death; the subsite, morphology, behavior and grade of the
tumour, and all information pertaining to the extent of dis-
ease at diagnosis. Extent of disease (stage) at diagnosis was
coded as localised (conﬁned to the organ of origin), regional
(spread to adjacent muscle, organ, fat or connective tissue, or
to regional lymph nodes), distant (distant metastasis) or
unknown. The data were linked to the population-based
mammographic screening service records in each region to
establish each woman’s screening status at diagnosis. We
deﬁned four groups: 1) women whose cancer was detected at
a routine screen, 2) women who presented with cancer fol-
lowing a negative screen but before being invited to their
next routine screen (interval cancers), 3) women who pre-
sented with cancer after at least one negative screen but who
had not attended their most recent appointment (lapsed
attenders), and 4) women who presented with cancer clini-
cally and had never attended screening. We compared
women in the screen-detected group (category 1) to all those
with non-screen-detected cancer (categories 2, 3 and 4).
In each region, all tumour records were linked to an eco-
logically deﬁned deprivation category based on the quintile of
the regional distribution of the percentage of unemployment
in their small area of residence. We used unemployment
because it is an internationally comparable measure of depri-
vation and because we have previously shown that differences
in survival by deprivation assessed with the unemployment
rate are similar to those measured with two highly validated
and locally deﬁned deprivation measures.1 We used the
smallest geographic areas available for the 2001 census to
maximise the accuracy of the ecological data in each country.
Unemployment rates were calculated for each census district
(CD) in New South Wales [mean population 539, standard
deviation (s.d.) 254] and each Lower-Level Super-Output
Area (LSOA, mean 1,513, s.d. 194) in West Midlands.
Despite the larger size of LSOAs, we have shown previously
that they are comparable to smaller areas of similar size to
the CDs when used to examine deprivation differences in
cancer survival in England, because they are more socially
homogeneous.10 Only 17 (0.1%) of records failed to match to
a small area; these women were excluded.
Methods
Our methods have been described in detail.9 Brieﬂy, we esti-
mated net survival using the non-parametric Pohar-Perme
estimator.11 We estimated expected survival from regional life
tables, derived for each year of follow-up. To account for the
potential effect of lead-time bias, we calculated additional sur-
vival time due to screening, E(s), for the screen-detected
group.12 We applied 10 separate simulations to obtain E(s)1,
E(s)2 . . . E(s)10, assuming that survival times were exponen-
tially distributed with a mean of E(s). We considered tumours
to be over-diagnosed if they would not have been detected
symptomatically during the woman’s lifetime or during the
study period (before December 31, 2006). For the screen-
detected group, we used the corrected survival times to esti-
mate non-parametric net survival for each of ten separate data
sets. We used the rules established by Rubin13 for the recombi-
nation of estimates in a multiple-imputation setting to derive
an overall estimate of net survival and its variance, adjusted for
lead-time bias and over-diagnosis. Where estimates were
recombined and no estimate could be given due to small num-
bers of deaths, we recalculated the estimates using at least ﬁve
of the simulations. These estimates gave an indication of the
trend in survival for groups with small numbers of deaths.
Results
We analysed data for 5,628 women in West Midlands (98.5%
of those eligible, mean age at diagnosis 53.7 years) and 6,396
women in New South Wales (99.9% of those eligible, mean
age at diagnosis 53.8 years). We excluded a small number of
women (0.7%) who were known to the registry only because
breast cancer had been mentioned on their death certiﬁcate
(DCOs) or if the sequence of dates provided was illogical.
Forty-four percent of women in New South Wales and
49% in West Midlands resided in afﬂuent localities (depriva-
tion quintiles 1 and 2, Table 1). In West Midlands 13.1%
were in the most deprived category compared to 17.0% in
New South Wales. There was a similar pattern by stage in
each region: more than half of the women were diagnosed
What’s new?
In the UK, affluent women are known to have higher breast cancer survival than deprived women, regardless of access to
screening. In this study, the authors examined net survival by socioeconomic status in the West Midlands (UK) and New South
Wales (Australia). They found a persistent ‘deprivation gap’ in survival in the former, but not in the latter region. Further inves-
tigation into the treatment and follow-up received by women with breast cancer across the social spectrum in the UK is
warranted.
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with a localised tumour, and more than a third had regional
disease at diagnosis. The cancer registry did not have sufﬁ-
cient information to derive stage of disease for 5.3% of
women in New South Wales and 8.9% in West Midlands.
Ten per cent of the women diagnosed in West Midlands and
7.6% of the women diagnosed in New South Wales died dur-
ing the period up to December 31, 2008.
Net survival at 5 years was higher in New South Wales
(93.4%) than in West Midlands (90.9%) (Table 2). The abso-
lute difference in the overall ﬁve-year net survival estimates
for the two regions was 2.5%, which is consistent with our
previous ﬁndings for women aged 50–69 diagnosed up to
1999.1 Women whose cancer was screen-detected had higher
survival than women whose cancer was not screen-detected
in both regions, even after adjustment for lead-time bias and
over-diagnosis.
There was an extremely striking difference between New
South Wales and West Midlands in the patterns of survival
by screening status and deprivation. In New South Wales,
net survival was very similar in both afﬂuent and deprived
groups up to 3.5 years after diagnosis, regardless of whether
or not the cancer had been screen-detected (Fig. 1a). In West
Midlands, in stark contrast, net survival for the deprived was
substantially lower than for the afﬂuent, for women with
screen-detected and non-screen-detected cancers, between 1
and 5 years after diagnosis (Fig. 1b). In the ﬁrst year after
diagnosis screen-detected women in West Midlands had sim-
ilar survival, irrespective of their deprivation status. Amongst
afﬂuent women who had been screen-detected cancer survival
was similar in New South Wales and West Midlands (97% 4
years after diagnosis).
Deprived women in the West Midlands whose cancer was
screen-detected had 5-year survival 3.3% lower than their
counterparts in New South Wales. In fact, their survival was
more similar to that of women in New South Wales whose
cancer was not detected by screening. The deprivation “gap”
in ﬁve-year survival within the West Midlands was around
3.5% in both screening groups, whereas in New South Wales
it was much smaller; 1.6% in the non-screen-detected group
and just 0.6% amongst the screen-detected group. Five-year
net survival for deprived women with non-screen detected
cancers in the West Midlands was 84%, 6% lower than New
South Wales (90%).
Similar patterns of survival were observed both amongst
women with localised disease and with regional spread. In
New South Wales, survival amongst afﬂuent and deprived
women was broadly similar for both localised and regional
disease, although the survival for deprived women with non-
screen detected cancer was lower than the other groups (Figs.
2a and 2b). Conversely, in the West Midlands deprived
women in both screening groups displayed lower survival
than afﬂuent women (Figs. 2c and 2d). Deprived women
diagnosed in the West Midlands with regional, non-screen
detected disease had the lowest survival: net survival was 80%
at four years.
Discussion
We have compared net survival among women eligible for
breast cancer screening who were diagnosed with an invasive
cancer between 1997 and 2006 in West Midlands and New
South Wales. We have demonstrated stark differences in the
pattern of survival by deprivation.
Deprivation-specific survival patterns
In New South Wales, survival was broadly similar amongst
afﬂuent and deprived women, irrespective of whether their
cancer was screen-detected. There were small survival differ-
ences between afﬂuent and deprived women for localised and
regional disease. By contrast, in the West Midlands, there
were large and persistent differences in survival between
deprived and afﬂuent women in both screen-detected and
non-screen-detected groups. Survival differences between
afﬂuent and deprived women were evident for both localised
and regional disease. In the West Midlands, the deprivation
“gap” was greatest for women diagnosed symptomatically
with regional disease.
Survival amongst afﬂuent women whose cancer was diag-
nosed via screening was very high (97% 4 years after
Table 1. Characteristics of the study cohort: women aged 50–65
(mean age 53.7 years) diagnosed with invasive breast cancer 1997–
2006 in New South Wales (Australia) and the West Midlands (UK)
New South
Wales
West
Midlands
N % N %
Total number of women 6,396 100.0 5,628 100.0
Mean age at diagnosis (years) 53.8 53.7
Deprivation Quintile1
1 - Affluent 1,388 21.7 1,455 25.9
2 1,437 22.5 1,294 23.0
3 1,277 20.0 1,110 19.7
4 1,198 18.7 1,024 18.2
5 - Deprived 1,088 17.0 736 13.1
Unknown 8 0.1 9 0.2
Extent of disease at diagnosis2
Localised 3,445 53.9 3,053 54.2
Regional 2,337 36.5 1,953 34.7
Distant 276 4.3 124 2.2
Unstaged 338 5.3 498 8.8
Vital status3
Dead 485 7.6 610 10.8
Alive 5,911 92.4 5,018 89.2
1Quintile of the unemployment rate of the small area of residence at
the 2001 census (see text).
2West Midlands data was recoded using the rules applied in New
South Wales.9
3Follow-up was complete for all women up to December 31, 2008.
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diagnosis) and very similar in West Midlands and New South
Wales. This is the only study to have shown a group of Aus-
tralian women with similar survival to a group of UK coun-
terparts; previous studies have all shown a large and
persistent survival disadvantage for all groups of women
diagnosed in the UK.1,14–17 This was, however, the only
group of women in which survival was similar.
Strengths and limitations
This study is unique because international differences in can-
cer survival between afﬂuent and deprived women have been
examined by the individual woman’s screening status. We
have achieved this via the linkage of each woman’s individual
cancer registration record to her screening service records in
two different countries as well as to the deprivation charac-
teristics of the immediate vicinity of each woman’s residential
address. We have used a conservative approach, whereby all
the women in our study would have received invitations to
screening from their 50th birthday. Our results are thus not
affected by the inclusion of women only eligible for screening
from older ages. We have corrected our results for lead-time
bias and for over-diagnosis. These biases together lead to
apparently better survival in the screen-detected group when
not appropriately considered. We discuss the interpretation
of these corrected rates in detail in the companion paper.9
There are, of course, limitations to our approach which must
be considered. First, we were not able to derive deprivation-
speciﬁc life tables for New South Wales, even though these were
available in the West Midlands. We conducted a sensitivity anal-
ysis to demonstrate the potential impact of this upon our results.
We ﬁrst applied deprivation-speciﬁc life tables to the West Mid-
lands data. We then used the mortality rate ratios between the
quintiles of unemployment in West Midlands to estimate plausi-
ble deprivation life tables for New South Wales. By doing so, we
assumed that the deprivation difference in the underlying risk of
death from causes other than breast cancer was the same in the
two regions. The use of deprivation life tables reduced the depri-
vation difference in survival, as would be expected. The reduc-
tion was relatively small, between 10 and 12% of the (relative)
difference in net survival observed in West Midlands could be
attributed to the absence of deprivation-speciﬁc life tables. In
New South Wales, where the observed differences were much
smaller, the impact of using a deprivation-speciﬁc life table was
much less marked, and resulted in almost no difference between
the deprivation groups. Thus, the absence of deprivation-speciﬁc
life tables in this study does not have a signiﬁcant impact upon
our conclusions, nor explain the differences observed in the
West Midlands.
Second, differences in the screening interval in the two
regions might potentially explain some of the deprivation-
speciﬁc differences in survival. In New South Wales women
are invited to be screened every 2 years, whereas in the West
Midlands the interval length is 3 years. This implies there
may be some residual confounding by stage of disease in the
screen-detected group, since within each stage grouping the
tumours detected by screening are likely to be relatively more
advanced in West Midlands. However, we observed similar
deprivation differences in survival amongst women who were
not screen-detected. Also, we observed the largest deprivation
“gap” for regional cancers in West Midlands. Together, these
observations suggest that although differences between the
two regions for the screen-detected group may be slightly
over-estimated, this cannot explain the differences observed
for the non-screen-detected group.
Table 2. Deprivation- and screening-specific net survival estimates: women aged 50–65 (mean age 53.7 years) diagnosed with invasive
breast cancer 1997–2006 in New South Wales (Australia) and the West Midlands (UK)
West Midlands New South Wales
Net Survival1, % (CI) Net Survival, % (CI)
Number (%) 1-year 5-year Number (%) 1-year 5-year
All 5,628 (100.0) 97.7 (97.2,98.1) 90.9 (89.9,91.7) 6,396 (100.0) 98.6 (98.3,98.9) 93.4 (92.6,94.1)
Affluent (quintiles 1&2) 2,749 (48.8) 98.2 (97.6,98.7) 92.6 (91.3,93.8) 2,825 (44.2) 98.6 (98.0,99.0) 94.1 (92.9,95.0)
Deprived (quintiles 3,4&5) 2,879 (51.2) 97.2 (96.5,97.8) 89.2 (87.8,90.4) 3,570 (55.8) 98.7 (98.2,99.0) 92.8 (91.7,93.8)
Screen-detected 2,524 (44.8) 99.9 (98.8,100.0) 97.5 (96.4,98.3) 2,335 (36.5) 99.8 (99.2,99.9) 98.5 (97.5,99.1)
Affluent 1,252 (22.2) 99.9 (95.2,100.0) 99.0 (97.2,99.6) 1,068 (16.7) 99.8 (98.7,100.0) 98.7 (96.9,99.4)
Affluent: corrected2 761 (13.5) 98.8 (97.9,99.7) 96.4 (94.4,98.4)* 625 (9.8) 99.0 (98.1,99.9)* 96.9 (94.9,98.9)*
Deprived 1,272 (22.6) 99.9 (98.0,100.0) 96.0 (94.2,97.3) 1,267 (19.8) 99.8 (98.8,100.0) 98.4 (96.8,99.2)
Deprived: corrected2 773 (13.7) 98.4 (97.5,99.4) 93.0 (90.6,95.5)* 765 (12.0) 98.8 (98.0,99.7) 96.3 (94.4,98.3)*
Non-screen detected 3,104 (55.2) 95.9 (95.1,96.6) 85.5 (84.1,86.9) 4,060 (63.5) 97.9 (97.4,98.3) 90.4 (89.3,91.5)
Affluent 1,497 (26.6) 96.8 (95.7,97.6) 87.5 (85.4,89.3) 1,757 (27.5) 97.8 (96.9,98.4) 91.3 (89.7,92.8)
Deprived 1,607 (28.6) 95.1 (93.8,96.0) 83.7 (81.6,85.6) 2,303 (36.0) 98.0 (97.3,98.6) 89.7 (88.1,91.1)
1Net survival estimate at the time of previous event before first or fifth anniversary of diagnosis.
2Cases are excluded due to imputed follow-up being greater than observed follow-up (see text). Values are the mean of the 10 imputed data sets
with the exception of * which is the mean of at least 5 estimates.
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Figure 1. Net survival estimates up to 6 years after diagnosis by deprivation and screening category: women aged 50–65 (mean age 53.7
years) diagnosed 1997–2006 and followed up to December 31, 2008. (a) New South Wales, Australia; (b) West Midlands, UK.
Figure 2. Net survival estimates up to 6 years after diagnosis by deprivation, screening and stage of disease at diagnosis: women aged
50–65 (mean age 53.7 years) diagnosed 1997–2006 and followed up to December 31, 2008. (a) New South Wales, localised cancers; (b)
New South Wales, regional cancers; (c) West Midlands, localised cancers; (d) West Midlands, regional cancers. Footnote to Figure 2: Cor-
rected survival is in paler colours when based on fewer than 10, but more than 5 recombined estimates (see text).
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A related concern is the possibility that the accuracy of the
staging information is different in each region and in particular
between deprivation categories. Poorer quality staging in the
West Midlands than in New South Wales (either due to less
detailed recording of staging variables or inadequate investiga-
tion) would lead to artefactually poorer stage-speciﬁc survival
in the West Midlands and/or in the more deprived groups.18
We consider that within each region reporting accuracy is
unlikely to be biased by deprivation group. It is, however, pos-
sible that women in New South Wales and in afﬂuent localities
in the West Midlands undergo more extensive staging investi-
gations. No information on the thoroughness of staging inves-
tigation (e.g., number of nodes examined) was obtained for this
study. However, there was no difference in the proportion of
women in each deprivation category with microscopically veri-
ﬁed cancer in either region, or between regions (over 99.4%
were microscopically veriﬁed). Missing data on stage of disease
did not vary signiﬁcantly between deprivation categories in
New South Wales. Although a greater proportion of women in
West Midlands were missing staging information in compari-
son to New South Wales, it was more frequently missing for
the afﬂuent than the more deprived in the West Midlands.
This may be related to the treatment of a small proportion of
afﬂuent women in the private sector (Lawrence G. Personal
Communication: Further analysis of ICBP treatment data v1.2,
2013). We thus have no strong evidence to suggest that thor-
oughness of staging or accuracy of reporting is a probable
explanation for the deprivation patterns observed, but further
work would be required to formally assess whether thorough-
ness of staging varies by socioeconomic status. Residual
confounding by stage also remains a possibility, whereby
tumours within each staging category are relatively more
advanced in deprived groups compared with the afﬂuent
groups.
Differences in survival are likely to be in part due to the dif-
ferences in the way screening is delivered in these two localities.
Because mammography is obtained in Australia both through
BreastScreen and the Medicare Beneﬁts Scheme (MBS), de
facto screening is likely to occur to a certain degree, which
means that some women in New South Wales recorded in our
study as never attenders, were, in fact, screen-detected. We
have shown, however, by a sensitivity analysis in which the
proportion of women in the screen-detected group was modi-
ﬁed, that the differences observed are robust to this bias.9
Although it is probable that we incorrectly allocated some
women to the never-attender group in New South Wales,
information on their personal characteristics and the features
of their cancer would not have been compromised since these
data items were collected from the Cancer Registry, rather than
via the screening service.
The ethnic proﬁle of each population must also be consid-
ered. In the Australian setting, it has been shown that breast
cancer survival is signiﬁcantly lower for those of Aboriginal
descent.19 However, these tumours represent only 1% of
breast cancers registered,20 so this will have a minimal impact
upon our results overall. By contrast, in West Midlands the
proportion of non-White women registered with breast can-
cer is nearer 4%, but we have shown that, after accounting
for deprivation, the survival of the Asian and Black women is
not different to that of White women.21,22
Overall, survival were high for the cohort of women exam-
ined. As a consequence, there were a relatively small number
of deaths which precluded modelling the effect of screening
status and deprivation on survival simultaneously. Small
numbers also prevented accurate estimations of survival for
women with distant disease. We therefore regrouped the
deprivation indicator into two categories. More extreme
deprivation differences would have been observed had we
examined all ﬁve quintiles of unemployment separately, or if
we had used the overall scale as a continuous variable. As
such, our results are indicative of a more marked underlying
trend. We chose to use a comparable measure of deprivation,
the quintile of unemployment, rather than a locally validated
score. This was so that we were able to directly compare the
results between the regions. The applicability of the propor-
tion of unemployed as a measure of deprivation for women of
this age group may be questioned. In the absence of individ-
ual data on socioeconomic status from the cancer registry,
ecological measures are the next best way to derive estimates
by deprivation in the population-based setting. In our previ-
ous work, we have shown that survival estimates are not very
sensitive to the score itself23 and that when comparing Aus-
tralia and England the use of a locally derived deprivation
measure in each country did not change the conclusions.1,24
Since we used, in both settings, the smallest possible geo-
graphical area to deﬁne the unemployment rate in the vicinity
of each women’s residential address, we are conﬁdent our
results are reﬂective of a true underlying trend of survival by
deprivation.
Possible explanations
Our results show that afﬂuent women presenting via screening
have similar survival in both New South Wales and West Mid-
lands, but that differences remain between the more and less
deprived in West Midlands and amongst those whose cancer is
not screen-detected. These differences cannot be explained in
full by either artefact or by the limitations of our approach.
The fact that screen-detected, afﬂuent women in both
localities have similar survival indicates that these women are
being treated with equal effectiveness, that is, similar out-
comes are attained in both localities. The fact that survival
for the screen-detected is similar for both deprivation groups
during the ﬁrst year following diagnosis further implies that
initial treatment amongst these women is equally effective in
the short-term. The magnitude of the deprivation disadvant-
age 5 years after diagnosis in the West Midlands was similar
for both screen-detected and non-screen-detected groups.
This further suggests that the underlying cause of the
deprivation-speciﬁc survival differences is unlikely to be sim-
ply whether the disease is symptomatic or not, or the mode
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of the woman’s presentation, or even the stage at which the
disease is detected.
We have previously conducted an extensive review of the ori-
gins of deprivation differences in survival7 where we
conceptualised three possible groups of explanations for socioe-
conomic differences; tumour factors (stage, morphology, grade),
patient factors (comorbidity, compliance with treatment), and
healthcare system factors (timeliness and effectiveness of treat-
ments received). In this study, we have observed deprivation dif-
ferences for both localised and regional disease. Additionally,
these are relatively young women (mean age 54 years) amongst
whom signiﬁcant comorbidities which contraindicate breast
cancer treatment are relatively infrequent, (Morris, M: personal
communication). We thus consider it more likely that the
deprivation-speciﬁc differences in breast cancer survival that we
have shown here for the West Midlands are due to the longer-
term effectiveness of the treatment received by afﬂuent women,
compared to more deprived women. These might feasibly arise
either from healthcare system or patient factors, symptom
awareness25 including thoroughness of staging leading to timeli-
ness and appropriateness of initial treatments,26 variations in
specialist treatments,27 subsequent clinical follow-up such as
variations in the initiation, adherence and persistence of post-
operative therapies,28 or from the complex interaction between
two or more of these factors. How and why these might vary so
considerably in the UK, where they do not appear to in Aus-
tralia, may in turn be related to a number of factors, including
the way treatment for breast cancer is decided, delivered,
received and funded,27 and how individuals from different
socio-demographic contexts interact with the healthcare system
including those professionals who work within it.29 Some
research has addressed this question in the context of racial dif-
ferences in the USA30 but research is lacking in the speciﬁc con-
text of deprivation differences in the UK.
Consistency with other studies
Our results for the West Midlands are consistent with a sepa-
rate analyses of women diagnosed in the same region8 and
largely consistent with the only other directly comparable
analysis on a separate cohort that we could identify. In this,
McKenzie et al.31 have shown a persistent deprivation gap
amongst screen-detected women diagnosed up to 2006 in the
South West of England amongst both screen-detected and
non-screen detected women. In that analysis, however, screen-
ing status was missing for 54% of the women. Further, no
adjustment was made for lead-time bias or over-diagnosis,
and thus these results cannot be considered to be reliable. In
other similar work outside the UK, the introduction of screen-
ing mammography in Italy has been associated with either an
attenuation32,33 and in the Netherlands an increase34 in the
differences between socioeconomic groups. None of these
studies examined survival by an individual woman’s screening
status, however, and are thus susceptible to ecological bias.
Conclusions
We have examined a cohort of young, economically active
women, diagnosed with breast cancer in the postscreening
era. The vast majority of these women would have been
treated with curative intent, and overall estimates of net sur-
vival were high. Amongst women resident in West Midlands,
we have identiﬁed large and persistent differences in survival
between afﬂuent and deprived women, for both screen-
detected and non-screen-detected groups. These differences
are not likely to be explained solely by artefact, or by patient
or tumour factors. Further investigations into the timeliness
and appropriateness of the treatments, adherence to treatment
and, or the clinical follow-up received by women with breast
cancer across the social spectrum are required, and whether
more recent improvements in cancer care have inﬂuenced
these patterns. Studies which address the question of how and
why such factors might vary with deprivation status in the
UK but not in Australia would also help to understand under-
lying causes of the deprivation gap in breast cancer survival in
the UK.
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